A federal judge ruled Sept. 28 that HHS must immediately cover 340B hospitals’ drug costs rather than waiting until 2023. The American Hospital Association and 340B organizations applauded the decision, which took “nearly six years,” Maureen Testoni, 340B Health President and CEO, said.
